Skip to main content
Premium Trial:

Request an Annual Quote

Augen Loosens the Tie and Sizes Up a Startup


“You’re probably wondering why I did this,” says Jeff Augen, speaking about his recent decision to leave a cushy post as worldwide director of strategy for IBM’s life science unit for his new job as president of New Haven, Conn.-based TurboWorx.

It turns out that, even post-dot-com crash, startup fever is contagious: While working with the smaller company under an alliance the two firms formed in the spring, Augen, whose previous experience was at EDS and Compaq, says he was simply won over by the company’s potential and felt the urge “to do something more entrepreneurial.”

Now splitting his time between Turbo- Worx (formerly TurboGenomics), a new post as entrepreneur-in-residence at investment bank Trautman, Wasserman & Co., and writing a textbook on post-genomic computational biology for science publisher Addison-Wesley, Augen says, “the first week has been pretty interesting.”

While running lean and keeping the company’s burn rate down, “we don’t plan to keep the revenue small,” he says. Sizing up the market for the type of parallelized workflow management software TurboWorx provides at “tens of billions of dollars,” Augen says he expects the company to capture “a few percent share of that market,” reaching the hundred-million-dollar range within the next five years — and that getting there will involve implementing key aspects of the IBM credo, such as forging partnerships rather than doing everything in-house.

— Bernadette Toner


The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.